Pharma Capital

Broker spotlight – AB Foods, Ophir Energy, Enquest, Premier Oil, BHP Billiton, Rio Tinto

Primark owner Associated British Food rose to the top of the FTSE 100 risers thanks to an upgrade from Goldman Sachs
Magnifying-Glass.jpg
Jamie_55a91591db06b.jpg

Primark owner Associated British Food (LON:ABF) rose to the top of the FTSE 100 risers thanks to an upgrade from Goldman Sachs, which switched from a ‘sell’ to a ‘buy’, and said the stock’s underperformance in the year to date now presents an investment opportunity.

“We estimate the US Primark stores will add £720mln to group EBIT by 2020, and believe near-term concerns from weak sugar, and dollar sourcing for Primark, have been well flagged,”  analyst Fulvio Cazzol said in a note.

Elsewhere, Barclay’s Capital upgraded Africa focussed exploration group Ophir Energy (LON:OPHR) to ‘overweight’ from ‘equal weight’.

The bank also nudged higher target prices for sector peers Enquest (LON:ENQ) and Premier Oil (LON:PMO), though the former remains an ‘underweight’ pick while it is recommended that investors are ‘overweight’ the latter.

Credit Suisse lifted its target price for energy sector engineer Weir (LON:WEIR) to 2205p from 1915p, and an ‘outperform’ rating was repeated.

Liberum Capital repeated ‘sell’ recommendations for miners BHP Billiton (LON:BLT) and Anglo America (LON:AAL), with the respective target prices reduced to 1150p from 1200p and 850p from 900p.

The broker also reduces its target for Rio Tinto (LON:RIO) to 2500p from 2600p, it is also deemed to be a ‘sell’.


© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.